Litcius/Paper detail

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt‐Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe

2022Blood Advances67 citationsDOIOpen Access PDF

Abstract

International audience

Topics & Concepts

MedicineNeutropeniaStem cellPancytopeniaHematopoietic stem cell transplantationAbsolute neutrophil countSurgeryInternal medicineGastroenterologyTransplantationBone marrowChemotherapyImmunologyBiologyGeneticsCAR-T cell therapy researchVirus-based gene therapy research
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy | Litcius